Delphine Diagnostics Participates in NJX Venture Summit
Delphine Diagnostics participated in the NJX Venture Summit in Skillman, New Jersey, engaging with startups, investors, and innovation leaders from across the...
Read moreNews
2026
Founder Participates in Global Tamil Entrepreneurs Summit 2026
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated as a panelist at the Global Tamil Entrepreneurs Summit 2026, held during the FeTNA...
Read more
Delphine Diagnostics Welcomes Sravya Kunisetty as Supply Chain Analyst Intern
Delphine Diagnostics is pleased to welcome Sravya Kunisetty as a Supply Chain Analyst Intern. A rising senior at Rutgers University–New Brunswick, Sravya will...
Read more
Founder Participates in Vanguard Life Science Forum
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated in the Vanguard Life Science Forum, joining startup CEOs and industry leaders to discuss...
Read more
Founder Attends Medlantic Conference on Healthcare Innovation
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated in the Medlantic Conference at the Princeton Innovation Center BioLabs, New Jersey. The conference brought...
Read more
Delphine Diagnostics Welcomes Gabriella Sebbag to the Team
Delphine Diagnostics is pleased to welcome Gabriella Sebbag to its molecular science team following the successful completion of her internship. A graduate...
Read more
Delphine Diagnostics Participates in TiEcon New Jersey
Delphine Diagnostics participated in the inaugural TiEcon New Jersey, joining entrepreneurs, investors, and business leaders from across the region. The event...
Read more
Delphine Diagnostics Joins the NJ AI Hub
Delphine Diagnostics has officially joined the New Jersey AI Hub, strengthening its commitment to advancing AI-driven innovation in healthcare. The NJ...
Read more
Delphine Diagnostics Raises Sepsis Awareness at Toddler & Baby Expo
Delphine Diagnostics participated in the Toddler & Baby Expo at Joint Base McGuire-Dix-Lakehurst, helping raise awareness about the risks of sepsis during pregnancy,...
Read more
Founder Shares Key Entrepreneurial Insights at IT Serve Alliance Event
Delphine Diagnostics’ Founder & CEO, Andy Bala, attended the IT Serve Alliance Synergy Event in New Jersey, where industry leaders shared experiences on...
Read more
Delphine Diagnostics Receives Innovation Grant Support
Delphine Diagnostics was selected as a recipient of a grant through an initiative supported by The Vanguard Network Group. The recognition...
Read more
Delphine Diagnostics Welcomes Mr. Raj Devalapalli as Senior Strategic Advisor to the Founder
Delphine Diagnostics is proud to announce the appointment of Mr. Raj Devalapalli as Senior Strategic Advisor to the Founder. His...
Read more
Building Trust Through Quality, Scientific Excellence, and Reliable Diagnostics
In healthcare, trust is one of the most valuable outcomes an organization can earn. Every diagnostic result has the potential...
Read more
Driving Innovation in Molecular Diagnostics for Accurate Infectious Disease Detection
Innovation is more than a guiding principle at Delphine Diagnostics—it is the foundation of everything we do. As the demand...
Read more
Advancing Sepsis Detection Through Smarter Diagnostics and Faster Clinical Intervention
Sepsis is one of the world’s most critical healthcare emergencies, affecting millions of people every year and remaining a leading...
Read more
Delphine Diagnostics Participates in Fierce JPM Week 2026
Delphine Diagnostics participated in Fierce JPM Week Virtual 2026, a leading healthcare and biopharma event bringing together industry leaders, innovators, and...
Read more
Redefining Healthcare Through Earlier and More Accurate Disease Detection
In today’s rapidly evolving healthcare landscape, timely and accurate diagnosis has become more important than ever. Every moment counts when...
Read more
Founder to Speak at TechUnited Conference on Healthcare Innovation
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated as a speaker at the TechUnited event held at Stevens Institute of Technology. The session...
Read more2025
Delphine Diagnostics Strengthens AI Capabilities for Infection Diagnosis
Delphine Diagnostics continues to advance its mission of improving infection diagnosis and treatment decision support through innovation. Beginning in Q1 2026,...
Read more
Delphine Diagnostics Highlights New Jersey’s Growing HealthTech Ecosystem
Delphine Diagnostics continues to support the rapid growth of New Jersey’s healthcare innovation ecosystem through the development of AI-enabled diagnostic...
Read more
Founder Shares Insights on Healthcare Innovation at TiE New Jersey
Delphine Diagnostics’ Founder & CEO, Andy Bala, participated as a panelist at “Shot in the Arm: Pioneering Innovative Startups in Healthcare &...
Read more
Delphine Diagnostics Appoints Raj Devalapalli as Senior Strategic Advisor
Delphine Diagnostics is pleased to announce the appointment of Mr. Raj Devalapalli as Senior Strategic Advisor to the Founder & CEO. A respected pharmaceutical...
Read more
Delphine Diagnostics Participates in TiE New Jersey HealthTech Panel
Delphine Diagnostics participated in a TiE New Jersey HealthTech panel discussion focused on the opportunities and challenges of bringing healthcare innovations to...
Read more
A promising step forward in infection diagnostics
It’s encouraging to see innovative diagnostic solutions like TriVerity from Inflammatix gaining recognition in the U.S. healthcare landscape. Such advancements...
Read more
Founder Joins New Jersey Life Sciences Workforce Leadership Council
Delphine Diagnostics’ Founder & CEO, Andy Bala, was appointed to the New Jersey Life Sciences Industry Partnership Workforce Leadership Council by the New...
Read more
Fueling the Future of Diagnostics: Andy Bala’s Pitch at Silicon Valley Demo Day
Andy Bala is excited to share this update regarding Delphine Diagnostic’s pitch to Investor community at Santa Clara CA, on...
Read more
Delphine Diagnostics to Present at BioNJ BioPartnering Conference 2025
Delphine Diagnostics participated in the BioNJ BioPartnering Conference 2025 at Liberty Science Center, New Jersey, showcasing the company’s vision and innovations in...
Read more
Delphine Diagnostics Receives Maternal and Infant Health R & D Award Grant from the New Jersey Commission on Science Innovation and Technology (NJ CSIT)
Princeton, NJ. March 5, 2025 New Jersey – Delphine Diagnostics, a pioneering company in medical diagnostics, is honored to announce that...
Read more2024
Delphine Diagnostics Showcases AI Innovations at BioNJ’s 2024 AI & Digital Health Day
Hoboken, NJ. November 18, 2024 Delphine Diagnostics is proud to announce its participation in the 2nd Annual AI & Digital...
Read more
Delphine Diagnostics partners with Rutgers Business School on an impactful project
New Brunswick, NJ. July 2024: As a part of the Industry Client Project course at Rutgers Business School, Delphine Diagnostics has...
Read more
Delphine Diagnostics presents at Wireless World Research Forum
Glassboro, NJ. June 2024: Andy Bala, Delphine DX’s Founder and CEO, was invited to speak at the Wireless World Research Forum at Rowan University on June...
Read more
Delphine Diagnostics CEO at ‘Entrepreneurs Exchange’
Princeton, NJ. June 2024: In the words of our CEO, Andy Bala: “I’m happy to have attended a valuable event, ‘Entrepreneurs...
Read more
Delphine Diagnostics well represented at the Princeton Tech Meetup
Princeton, NJ. January 2024: Andy Bala, CEO of Delphine Diagnostics, attended the Princeton Tech Meetup focused on Artificial Intelligence in Healthcare....
Read more2023
Delphine Diagnostics Takes Center Stage at NJ Cores Partnering Conference
Princeton, NJ. June 2023:Delphine Diagnostics, a pioneering figure in advanced medical diagnostics, proudly showcased its commitment to scientific collaboration and...
Read more
Delphine Diagnostics is at the Roundtable Discussion in Camden
Camden, NJ. April 2023: New Jersey’s Commission on Science, Innovation, and Technology (CSIT) recently organized a valuable event at Rutgers and...
Read more
Panel on Use of Academic and Federal Core Research/Lab Facilities in New Jersey
Princeton, NJ. March 15, 2023: The panel discussion on “Use of Academic and Federal Core Research/Lab Facilities in New Jersey” was...
Read more2022
BioNJ Manufacturing Briefing 2022
Newark, NJ. September 9, 2022: Delphine Diagnostics’ CEO, Andy Bala, attended Manufacturing Briefing 2022 at NJIT and NJ Innovation Institute, both...
Read more
Bionj’s Twelfth Annual Biopartnering Conference
New Jersey, May 9, 2022: Biotech Industry Association in New Jersey ‘BioNJ’ had organized a BioPartnering networking event on May 9,...
Read more
The state of the state of manufacturing
Trenton, NJ, May 5, 2022: Delphine Diagnostics Inc’s CEO, Andy Bala, attended the State of the State of Manufacturing. The event took...
Read more
Delphine Diagnostics Inc. Participated in the BAJ Accelerator Program
New York, January 2022: Delphine Diagnostics Team joined the NYC-based BAJ Accelerator Program as of January 2022 Cohort #7. The...
Read moreFollow our latest updates and insights.
For media, partnership, investor, career, or customer inquiries, connect with our team.